HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takashi Koyano Selected Research

Takashi Koyano Research Topics

Disease

6Neoplasms (Cancer)
01/2017 - 01/2006
2Pancreatic Neoplasms (Pancreatic Cancer)
02/2011 - 11/2008
2Adenocarcinoma
03/2010 - 08/2009
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2020
1Carcinoma (Carcinomatosis)
01/2017
1Hemolysis
06/2012
1Colonic Neoplasms (Colon Cancer)
04/2009
1Carcinogenesis
04/2009
1Prostatic Neoplasms (Prostate Cancer)
11/2008
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2006
1Leukemia P388
06/2003

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
01/2017 - 11/2008
2Death Domain ReceptorsIBA
09/2009 - 01/2006
1Cardiac GlycosidesIBA
09/2020
1Biomarkers (Surrogate Marker)IBA
01/2017
1Epithelial Cell Adhesion MoleculeIBA
01/2017
1LuteinIBA
06/2012
1lyseninIBA
06/2012
1PorinsIBA
06/2012
1SphingomyelinsIBA
06/2012
1Patched-1 ReceptorIBA
05/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2010
1TNF-Related Apoptosis-Inducing LigandIBA
03/2010
11,3,5,8- tetrahydroxy- 2,4- bis(3- methyl- 2- butenyl)xanthoneIBA
03/2010
1Messenger RNA (mRNA)IBA
08/2009
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
08/2009
1beta CateninIBA
04/2009
1TriterpenesIBA
11/2008
1Vincristine (Oncovin)FDA LinkGeneric
06/2003
1wrightiamine AIBA
06/2003

Therapy/Procedure

4Therapeutics
01/2017 - 01/2006